Pfizer Vaccine For 12 To 15-Year-Olds Approved By UK Regulator

We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective in this age group, said the head of the Medicines and Healthcare products Regulatory Agency.

Britain's medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a "rigorous review", following similar assessments in the EU and US. "We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," said June Raine, head of the Medicines and Healthcare products Regulatory Agency.